COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
NeoVista develops medical devices for treating wet age-related macular degeneration, including the VIDION ANV system and a one-time epimacular strontium-90 beta-radiation brachytherapy procedure, in phase 3 FDA trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors